Non-Ambulatory SCI Walk Using a Robotic Exoskeleton: Effect on Bone and Muscle

Not Applicable

• Conditions: Spinal Cord Injury
• Interventions: Device: Exoskeleton Training; Other: Muscle Biopsies; Other: MRI

• Registration Number: NCT02324322
• Lead Sponsor: Kessler Foundation

Brief Summary

The purpose of this research study is to evaluate an exoskeleton device and mobility skills in the device.

Detailed Description

Currently, the treatment of muscle and bone deterioration after SCI is very limited; therefore, there is a definite need to further understand the mechanism of breakdown in the musculoskeletal system after a SCI, and, more importantly, find a clinical strategy that will treat muscle and bone loss.

This pilot research grant will collect results that will be used for the design of a multi-site randomized controlled clinical trial to determine whether a Robotic Exoskeleton training \[100 sessions; 1hr/session; 4-5 sessions/week\] can improve musculoskeletal outcomes more than other current interventions. If the overall objective is to use the progression of technology to enhance functional ambulation for persons with a spinal cord injury, then the investigators need to evaluate the health benefits associated with continual use of the device.

The study will be a prospective, single-group, repeated measure design using a 2 -month lead in to establish stability, 5-month intervention phase and 2 -month follow-up phase for retention will be performed. Each participant will be used as his or her own control. This project will be completed at two sites: Kessler Foundation will be the lead site that will be under the direction of Dr. Gail F Forrest (Principal Investigator) and Spinal Cord Damage Research Center, James J Peters VA Medical Center under the direction of Dr. Ann M. Spungen (collaborator). Both sites have exoskeletal-assisted walking programs.

Study Timeline

• Study Start: 2013-10
• Study First Submitted: 2014-12-03
• Study First Submitted QC: 2014-12-23
• Study First Posted: 2014-12-24
• Status Verified: 2017-03
• Last Update Submitted: 2017-03-20
• Last Update Posted: 2017-03-22
• Primary Completion: 2017-12
• Study Completion: 2018-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

• Must be a non walker with a SCI greater than 1 year post injury
• Must have a neurological level between the C6-T10 level
• Must have a lower extremity score greater than 1 as defined by the neurological exam
• Must be between 21 and 45 years old
• Must be wheelchair reliant 100% of time
• Must have knee bone mineral density greater than .5755 gm/cm2 as determined by study staff
• Must have a score on the Modified Ashworth Scale equal to or less than 3 as determined by the study staff
• Must be able to tolerate upright standing for up to 30 minutes
• Must have joint range of motion within normal functional limits for ambulation
• Must have sufficient upper body strength to balance using the walker while wearing the exoskeleton
• Must have a height between 62 inches or 74 inches
• Must weigh less than 220 lbs,(limitation of the devices)
• Must have no joint tightening of any extremity that limits movement during walking with the assistive devices
• Must have no medical issue that precludes full weight bearing, ambulation or exercise intolerance in the exoskeleton (e.g. orthopedic injuries, pain, severe spasticity)
• Must have no skin issues (e.g. pressure sores) that would prevent wearing the device
• Must have no memory and/or thinking disability (e.g. due to brain injury)
• Must be able to follow directions well and demonstrate learning capability
• Must be able to physically fit into the exoskeletal device

Exclusion Criteria

• A woman who is pregnant, lactating, or post-menopausal
• Wearing an external device that supports the spinal column or the head, neck, or trunk
• Have persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in robotic system)
• Have had a hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study or no presence of major cardiovascular or pulmonary disease, lower extremity deep vein thrombosis (within the last three months)
• Have been taking any medications known to influence bone metabolism

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Exoskeleton training	Exoskeleton Training	To examine the effectiveness of robotic exoskeleton-assisted over ground walking (5 hrs. p/wk, 100 sessions, 20 wks = 100 hrs) to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI. Combined with our current training protocol where people step 1500-2000/session we predict that the 2,000 lower extremity muscle contractions will be sufficient in our proposed exoskeletal study. MRI's will be performed to accurately assess muscle CSA of each lower limb to determine individual's muscle thigh and shank volume. Muscle Biopsies for the quadricep muscle will be performed to determine changes in BMD and bone structure due to intensive exoskeleton assisted walking.
Exoskeleton training	MRI	To examine the effectiveness of robotic exoskeleton-assisted over ground walking (5 hrs. p/wk, 100 sessions, 20 wks = 100 hrs) to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI. Combined with our current training protocol where people step 1500-2000/session we predict that the 2,000 lower extremity muscle contractions will be sufficient in our proposed exoskeletal study. MRI's will be performed to accurately assess muscle CSA of each lower limb to determine individual's muscle thigh and shank volume. Muscle Biopsies for the quadricep muscle will be performed to determine changes in BMD and bone structure due to intensive exoskeleton assisted walking.
Exoskeleton training	Muscle Biopsies	To examine the effectiveness of robotic exoskeleton-assisted over ground walking (5 hrs. p/wk, 100 sessions, 20 wks = 100 hrs) to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI. Combined with our current training protocol where people step 1500-2000/session we predict that the 2,000 lower extremity muscle contractions will be sufficient in our proposed exoskeletal study. MRI's will be performed to accurately assess muscle CSA of each lower limb to determine individual's muscle thigh and shank volume. Muscle Biopsies for the quadricep muscle will be performed to determine changes in BMD and bone structure due to intensive exoskeleton assisted walking.

Primary Outcome Measures

Name	Time	Method
Bilateral Muscle Volume (surrogate for strength)for thigh and shank will be the primary outcome measurement.	100 hours	To examine the effectiveness of exoskeleton assisted overground walking (5 hours per week, 100 sessions, 20 weeks = 100 hours) to induce positive changes in muscle volume and structure of the lower limbs for non-ambulatory persons with SCI.

Secondary Outcome Measures

Name	Time	Method
Muscle Activation	100 hours	To examine the effect of exoskeletal assisted walking for 100 sessions in increasing further muscle volume through muscle activation to increase muscle size and strength and mitigate the secondary complications that follow SCI.

Trial Locations

Locations (1)

Kessler Foundation; 🇺🇸 West Orange, New Jersey, United States